Blaze.tech Raises Additional $5M, Bringing Pre-Seed Funding to $8.5M

Blaze.tech, a Los Angeles-based AI app-building platform purpose-built for healthcare, raised an additional $5M in pre-seed funding from Friale, bringing the total pre-seed financing to $8.5M.

The company intends to use the capital to expand its healthcare-specific product capabilities, deepen integrations with healthcare systems and clearinghouses, and grow its team to support continued customer demand.

The financing matters because Blaze is building around a more defensible proposition than generic no-code software. In regulated markets, building faster only matters if the resulting application can handle permissions, audit trails, integrations, deployment controls, and sensitive data without creating a second problem for the buyer.

What Happened

Friale invested an additional $5M in Blaze.tech, bringing the company's total pre-seed financing to $8.5M. The new capital will support product expansion, deeper integrations with healthcare systems and clearinghouses, and team growth as Blaze responds to customer demand.

The financing builds on Blaze's $3.5M pre-seed, which financed the company's earlier development and launch. The additional $5M gives Blaze more capital to deepen the healthcare-specific capabilities that now define its strategy.

That progression sharpens the original proposition. Blaze began with the idea that nontechnical teams should be able to turn operating knowledge into software without waiting for every idea to become a conventional engineering project. Its healthcare focus adds another requirement: those applications also have to operate within the security, compliance, integration, and workflow constraints of a regulated industry.

Why the Healthcare Focus Matters

No-code software is easy to describe and difficult to defend. A faster interface can shorten the distance between an idea and an application, but serious healthcare buyers need a longer list of answers: who can access patient data, how actions are logged, how the software connects to healthcare systems, and what happens when a production workflow must change.

Blaze.tech is an AI-driven platform purpose-built for healthcare that allows organizations to design, build, and deploy custom, HIPAA-compliant software without traditional development. The platform generates multi-portal applications, fully structured relational databases, and end-to-end workflows in minutes, combining AI generation with deterministic, auditable workflows, guardrails, and separate development, staging, and production environments designed to protect patient data.

The company maintains SOC 2 Type II and HITRUST e1 certifications while supporting native e-prescribing and integrations with EHRs and clearinghouses. Those capabilities put healthcare requirements near the center of the product rather than treating them as enterprise accessories added after an application has already been built.

This is the strategic case behind the capital. Blaze is not merely promising to help teams build software faster. It is trying to make that speed credible inside workflows where trust, compliance, integration depth, and deployment discipline determine whether software can move into production at all.

The Team Behind Blaze.tech

Blaze is led by co-founders and co-CEOs Nanxi Liu and Tina Wojcik. Their operating thesis centers on giving healthcare organizations the ability to turn workflow knowledge into custom software without requiring traditional development for every application.

That approach addresses a practical gap inside healthcare organizations. The people closest to an operational problem often understand exactly what a workflow needs to accomplish, while the technical work required to build, integrate, secure, and maintain custom software can slow the path from that knowledge to a production application.

Blaze is building around that divide. AI generation can accelerate application creation, while deterministic workflows, guardrails, controlled environments, and healthcare integrations provide the structure required to move those applications beyond experimentation.

Why the Additional Capital Matters

The strongest early-stage companies rarely win because they make a broad category slightly more convenient. They win when convenience is rebuilt around the constraints of a market that general-purpose competitors understand only from a sales deck.

Healthcare software has exactly those constraints. Patient data, clinical workflows, identity, auditability, EHR connectivity, clearinghouses, and controlled deployment create friction that cannot be waved away by an AI demo. A product that removes development effort while respecting those constraints can compete for a different kind of budget than a generic internal-tools builder.

The additional $5M gives Blaze more resources to deepen that specialization. Product development can move further into healthcare-specific requirements, integrations can connect the platform more closely to the systems where healthcare work already happens, and team expansion can support customer demand as deployments grow.

Blaze's $8.5M pre-seed therefore reflects more than additional runway. It gives the company capital to keep narrowing the distance between rapid AI application generation and the operational requirements that determine whether healthcare software can actually be used.

The Bigger Industry Shift

AI-assisted software creation is expanding who can build applications, but regulated organizations still need governance that survives beyond the prompt box. The market is likely to reward platforms that combine faster construction with deployment discipline, traceable permissions, structured data, and integrations into the systems where work already happens.

Blaze.tech's strategy is one version of that shift. The company is betting that healthcare organizations want the flexibility of an AI builder without accepting the operational risk of an improvised stack, and that purpose-built infrastructure can turn rapid application creation into trustworthy production software.

The broader lesson is less glamorous than the usual automation pitch, which is precisely why it matters. Speed becomes durable only when the product understands the rules of the room. With $8.5M in pre-seed financing, Blaze now has more capital to prove that healthcare is the room where its approach can matter most.